A phase 2, double-blinded, placebo-controlled trial of toll-like receptor 7/8/9 antagonist, IMO-8400, in dermatomyositis

Yoo Jung Kim, Elena Schiopu, Katalin Dankó, Tahseen Mozaffar, Srinivas Chunduru, Kirstin Lees, Namita A. Goyal, Jeffrey Sarazin, David F. Fiorentino, Kavita Y. Sarin

Research output: Contribution to journalArticlepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)1160-1162
Number of pages3
JournalJournal of the American Academy of Dermatology
Issue number4
StatePublished - Apr 2021
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Cite this